Kanabo Group (LSE:KNB) Capital Expenditure : £-0.53 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Kanabo Group's cash flow for capital expenditures for the six months ended in Dec. 2023 was £-0.32 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.53 Mil.

Kanabo Group Capital Expenditure Historical Data

The historical data trend for Kanabo Group's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group Capital Expenditure Chart

Kanabo Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-0.04

-0.15

-0.53

Kanabo Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capital Expenditure	Get a 7-Day Free Trial								-0.01	-0.14	-0.01	-0.21	-0.32

Kanabo Group Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.53 Mil.

Kanabo Group (LSE:KNB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

3WD:Germany

Address

137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ

Website

https://www.kanabogroup.com

Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group (LSE:KNB) Headlines

No Headlines